Clinical Trials Directory

Trials / Completed

CompletedNCT03216265

A Proof of Concept Clinical Study to Investigate the Effects of an Experimental Cosmetic Moisturiser on the Barrier Function of Human Skin on the Face and Forearm

A Proof of Concept (POC) Clinical Study to Investigate the Effects of a Developmental Cosmetic Moisturising Cream on the Barrier Function of Human Skin on the Face and Forearm

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
69 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The objective of this POC clinical study is to investigate the impact of the test product (Developmental Cosmetic Moisturising Cream) on skin barrier function and skin moisturisation on the forearm and face after 4 weeks of twice daily application compared to no treatment in participants with dry sensitive skin.

Detailed description

Areas on the volar forearm and each side of the face, will be selected for measurements of transepidermal water loss (TEWL) and corneometry to be conducted . A physical challenge and a regression period of 5 days is also included to evaluate skin barrier function and moisturisation. A regression period of 5 days (Days 30, 31, 32, 33 and 34) of no study product use following the 4 week treatment phase is also included to evaluate skin barrier function and moisturisation.

Conditions

Interventions

TypeNameDescription
OTHERTest product (Moisturising cream)Participants will be instructed to apply their assigned product to the randomly assigned sites twice daily (in the morning and evening).
OTHERPositive control (Commercial market place moisturising cream)Participants will be instructed to apply their assigned product to the randomly assigned sites twice daily (in the morning and evening).
OTHERNo treatmentNo treatment.

Timeline

Start date
2017-02-23
Primary completion
2017-04-19
Completion
2017-04-24
First posted
2017-07-13
Last updated
2019-04-18
Results posted
2019-04-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03216265. Inclusion in this directory is not an endorsement.